Delivery Order SPE2DB24D1021-SPE2DB24FETMC
Award Date 8/16/24
Potential Completion Date 8/19/24
Potential Value $4.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order valued at $31,971.06 for the medical product REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The award has an ultimate completion date of January 13, 2025. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 that serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,405.24 firm fixed-price delivery order contract is for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a specialty medication. The contract has an ultimate completion date of March 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML, a pharmaceutical product, to the U.S. government. The contract, valued at $17,588.13, was awarded by the Medical Supply Chain, which is part of the Defense agency. Amerisourcebergen, a major pharmaceutical distribution company, has been awarded this Firm Fixed Price delivery order contract with a completion date of May 16, 2024. The company holds a...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,437.19, is a Firm Fixed Price Delivery Order for the supply of REBIF 44 MCG/0.5 ML SYRINGE 0.5ML. The contract has an ultimate completion date of February 12, 2025 and was awarded on February 11, 2025. This contract award is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This is a $28,161.74 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product. The contract has an ultimate completion date of November 19, 2024 and was awarded on November 18, 2024. There is no set-aside designation noted for this contract. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that has...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a specialty medication, to support military healthcare programs. The contract has a ceiling value of $13,021.65 and runs through March 7, 2025. It is a firm fixed-price contract with no set-aside designation, indicating open competition....
- Amerisourcebergen Drug Corporation, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order against an indefinite delivery contract held with the Defense Logistics Agency Troop Support Medical. This $34,217.69 order is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML prefilled syringes to the place of performance in Conshohocken, Pennsylvania by November 9, 2023. As a prime contractor supporting DLA Troop Support Medical programs, Amerisourcebergen...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML, a pharmaceutical product, and has a ceiling value of $8,813.75. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of April 9, 2025. This contract award is not associated with a set-aside designation....
- This federal contract award, valued at $4,101.30, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor AmerisourceBergen Drug Corp. The contract, which is a Delivery Order under a larger Indefinite Delivery Contract (IDC), covers the provision of REBIF SYR 0.5ML 12S, a pharmaceutical product. The contract has a firm fixed price and is set to run until November 13, 2024. While the original solicitation is not provided, the contract appears to be part of a...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide a specialty pharmaceutical product, REBIF REBIDOSE 44 MCG/0.5 ML 0.5ML. The total ceiling value of this delivery order is $163,843.99. Amerisourcebergen Drug Corp is the prime contractor on a larger indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31,...